Zobrazeno 1 - 10
of 365
pro vyhledávání: '"Olivier Varenne"'
Autor:
Antoine Dusonchet, Olivier Varenne, Tania Puscas, Malika Saadi, Albert Hagege, David Calvet, Jean‐Louis Mas, Guillaume Turc
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Background Patent foramen ovale (PFO) is causally associated with stroke in some patients younger than 60 years, especially when it is large or associated with an atrial septal aneurysm (ASA). After 60 years of age, this association is less well unde
Externí odkaz:
https://doaj.org/article/374688df9dc045b588b429c5450c7673
Autor:
Emmanuel Gall, Donia Mafi, Tahar Ghannam, Pierre Brami, Vincent Pham, Olivier Varenne, Fabien Picard
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 23, p 7275 (2023)
Out-of-hospital cardiac arrest (OHCA) continues to be a major global cause of death, affecting approximately 67 to 170 per 100,000 inhabitants annually in Europe, with a persisting high rate of mortality of up to 90% in most countries. Acute coronary
Externí odkaz:
https://doaj.org/article/dd1bd4fa672743608a8cf8d4eff1f06b
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 21, p 6711 (2023)
Cardiovascular disease, including ischemic heart disease, is the leading cause of death worldwide, and percutaneous coronary interventions (PCIs) have been demonstrated to improve the prognosis of these patients on top of optimal medical therapy. PCI
Externí odkaz:
https://doaj.org/article/1a62da83814a4725a71b9c2e80047f1f
Autor:
Caroline Chong Nguyen, Denis Duboc, Dominique Rainteau, Harry Sokol, Lydie Humbert, Philippe Seksik, Adèle Bellino, Hendy Abdoul, Naïm Bouazza, Jean-Marc Treluyer, Malika Saadi, Karim Wahbi, Heithem Soliman, Benoit Coffin, André Bado, Maude Le Gall, Olivier Varenne, Henri Duboc
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Synthetized by the liver and metabolized by the gut microbiota, BA are involved in metabolic liver diseases that are associated with cardiovascular disorders. Animal models of atheroma documented a powerful anti-atherosclerotic effect of bil
Externí odkaz:
https://doaj.org/article/1c4ea355bf004c9ebc1162d31405978c
Publikováno v:
Archives of Cardiovascular Diseases. 116:272-281
Autor:
Julien Adjedj, Fabien Picard, Maarten Vanhaverbeke, Bernard De Bruyne, Alain Cariou, Ming Wu, Stefan Janssens, Olivier Varenne
Publikováno v:
Intensive Care Medicine Experimental, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Background Several indices exist to assess cerebral perfusion after cardiac arrest (CA). We aimed to investigate a new approach allowing absolute flow and microvascular resistance measurement based on selective arterial continuous thermodilu
Externí odkaz:
https://doaj.org/article/3b65cbe2ab1b4f6fb4b745077ec4332b
Publikováno v:
Archives of Cardiovascular Diseases. 116:33-40
The prevalence and significance of abnormal epicardial coronary vasomotor reactivity (ACVR) in patients with symptoms compatible with myocardial ischaemia remains ill-defined. Our diagnostic strategy is to perform a provocative test (PT) in every pat
Publikováno v:
Archives of Cardiovascular Diseases. 116:227-229
Autor:
Gabriel, Seret, Vincent, Pham, Driss, Laghlam, Marine, Diefenbronn, Thibaud, Brunet, Olivier, Varenne, Florence, Dumas, Alain, Cariou, Fabien, Picard
Publikováno v:
Archives of Cardiovascular Diseases. 115:552-561
Patients with out-of-hospital cardiac arrest (OHCA) due to acute coronary syndromes (ACS) who undergo percutaneous coronary intervention (PCI) are at high risk of bleeding and thrombosis. While predictive bleeding and stent thrombosis risk scores hav
Autor:
Raffaele Piccolo, Kaare H. Bonaa, Orestis Efthimiou, Olivier Varenne, Andrea Baldo, Philip Urban, Christoph Kaiser, Adam de Belder, Pedro A. Lemos, Tom Wilsgaard, Jörg Reifart, Expedito E. Ribeiro, Patrick WJC Serruys, Robert A. Byrne, Jose M. de la Torre Hernandez, Giovanni Esposito, William Wijns, Peter Jüni, Stephan Windecker, Marco Valgimigli
Publikováno v:
The American Journal of Cardiology. 182:8-16
New-generation drug-eluting stents (DES) strongly reduce restenosis and repeat revascu- larization compared with bare-metal stents (BMS) for percutaneous coronary interven- tion. There is residual uncertainty as to whether other prognostically releva